BIOLASE (BIOL) Competitors $0.0010 0.00 (0.00%) As of 07/23/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock BIOL vs. DYNT, NUWE, NAYA, SONX, IONM, HSDT, AFIB, BRSH, SDCCQ, and GMVDFShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Dynatronics (DYNT), Nuwellis (NUWE), NAYA Biosciences (NAYA), Sonendo (SONX), Assure (IONM), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry. BIOLASE vs. Its Competitors Dynatronics Nuwellis NAYA Biosciences Sonendo Assure Helius Medical Technologies Acutus Medical Bruush Oral Care SmileDirectClub G Medical Innovations BIOLASE (NASDAQ:BIOL) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk. Which has better earnings and valuation, BIOL or DYNT? Dynatronics has lower revenue, but higher earnings than BIOLASE. Dynatronics is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBIOLASE$48.83M0.00-$20.63M-$14.940.00Dynatronics$33.60M0.04-$2.70M-$0.78-0.12 Which has more volatility and risk, BIOL or DYNT? BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Do institutionals and insiders hold more shares of BIOL or DYNT? 8.8% of BIOLASE shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Comparatively, 8.0% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer BIOL or DYNT? In the previous week, BIOLASE's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score. Company Overall Sentiment BIOLASE Neutral Dynatronics Neutral Do analysts recommend BIOL or DYNT? BIOLASE currently has a consensus target price of $1.20, suggesting a potential upside of 119,900.00%. Given BIOLASE's stronger consensus rating and higher possible upside, analysts plainly believe BIOLASE is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIOLASE 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BIOL or DYNT more profitable? Dynatronics has a net margin of -8.35% compared to BIOLASE's net margin of -41.65%. Dynatronics' return on equity of -41.81% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets BIOLASE-41.65% -1,782.73% -55.31% Dynatronics -8.35%-41.81%-9.56% SummaryBIOLASE and Dynatronics tied by winning 7 of the 14 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$33K$263K$5.70B$9.48BDividend YieldN/AN/A4.59%3.99%P/E Ratio0.00N/A27.9019.95Price / Sales0.000.01442.19102.72Price / CashN/AN/A36.5558.97Price / Book-0.010.018.635.90Net Income-$20.63M-$40.78M$3.24B$258.42M7 Day PerformanceN/AN/A3.22%1.94%1 Month PerformanceN/AN/A10.72%12.02%1 Year PerformanceN/AN/A34.94%20.81% BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE1.0847 of 5 stars$0.00flat$1.20+119,900.0%-98.7%$33K$48.83M0.00160DYNTDynatronicsN/A$0.09-7.4%N/A-71.0%$935K$33.60M-0.11200Gap DownNUWENuwellis3.0423 of 5 stars$7.81+13.5%$714.00+9,042.1%-92.1%$812K$8.79M-0.0170News CoverageHigh Trading VolumeNAYANAYA BiosciencesN/A$0.78-5.4%$24.00+2,993.6%N/A$517K$6.23M0.0010High Trading VolumeSONXSonendoN/A$1.15flatN/A+1,508.4%$493K$44.40M-0.02250IONMAssureN/A$0.03flatN/A-98.0%$91K$149K0.00130Gap UpHSDTHelius Medical Technologies0.439 of 5 stars$7.35-8.7%N/A-98.7%$74K$520K0.0030High Trading VolumeAFIBAcutus MedicalN/A$0.00+10.0%N/A-99.5%$66K$7.16M0.00340Gap DownBRSHBruush Oral CareN/AN/AN/AN/A$44K$2.92M0.0011Gap DownSDCCQSmileDirectClubN/AN/AN/A-96.4%$40K$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072 Related Companies and Tools Related Companies Dynatronics Alternatives Nuwellis Alternatives NAYA Biosciences Alternatives Sonendo Alternatives Assure Alternatives Helius Medical Technologies Alternatives Acutus Medical Alternatives Bruush Oral Care Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOL) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.